Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 34% ± 13% | |
| glutamatergic neuron | 8 studies | 34% ± 21% | |
| astrocyte | 8 studies | 33% ± 19% | |
| endothelial cell | 6 studies | 21% ± 4% | |
| oligodendrocyte precursor cell | 6 studies | 34% ± 11% | |
| adipocyte | 4 studies | 25% ± 2% | |
| interneuron | 4 studies | 41% ± 21% | |
| GABAergic neuron | 4 studies | 45% ± 20% | |
| fibroblast | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 519.00 | 245 / 245 | 100% | 6.57 | 500 / 502 |
| breast | 100% | 487.83 | 459 / 459 | 99% | 8.76 | 1112 / 1118 |
| brain | 100% | 391.96 | 2635 / 2642 | 100% | 8.78 | 702 / 705 |
| ovary | 100% | 540.08 | 180 / 180 | 99% | 6.86 | 427 / 430 |
| thymus | 100% | 536.15 | 653 / 653 | 99% | 6.55 | 600 / 605 |
| pancreas | 100% | 294.29 | 327 / 328 | 98% | 6.11 | 175 / 178 |
| esophagus | 100% | 422.36 | 1440 / 1445 | 98% | 9.58 | 179 / 183 |
| uterus | 100% | 499.60 | 170 / 170 | 97% | 7.61 | 444 / 459 |
| adrenal gland | 100% | 478.55 | 258 / 258 | 97% | 5.00 | 222 / 230 |
| skin | 100% | 477.40 | 1806 / 1809 | 97% | 10.19 | 456 / 472 |
| kidney | 100% | 449.42 | 89 / 89 | 96% | 5.64 | 864 / 901 |
| bladder | 100% | 459.24 | 21 / 21 | 94% | 6.42 | 473 / 504 |
| lung | 95% | 346.89 | 549 / 578 | 98% | 9.13 | 1132 / 1155 |
| liver | 100% | 397.54 | 226 / 226 | 91% | 4.63 | 371 / 406 |
| stomach | 100% | 403.96 | 358 / 359 | 90% | 6.89 | 257 / 286 |
| intestine | 100% | 491.21 | 966 / 966 | 81% | 5.32 | 427 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.00 | 29 / 29 |
| spleen | 100% | 736.84 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.99 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.54 | 1 / 1 |
| adipose | 100% | 419.04 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 311.94 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 286.07 | 845 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 262.47 | 783 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 80% | 4.14 | 64 / 80 |
| peripheral blood | 72% | 364.53 | 667 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006393 | Biological process | termination of mitochondrial transcription |
| GO_0032392 | Biological process | DNA geometric change |
| GO_0006353 | Biological process | DNA-templated transcription termination |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0042645 | Cellular component | mitochondrial nucleoid |
| GO_0003690 | Molecular function | double-stranded DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003676 | Molecular function | nucleic acid binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | MTERF1 |
| Protein name | Mitochondrial transcription termination factor 1 (cDNA FLJ51270, highly similar to Transcription termination factor, mitochondrial) Mitochondrial transcription termination factor 1 Transcription termination factor 1, mitochondrial (Mitochondrial transcription termination factor 1) (mTERF) (mTERF1) |
| Synonyms | MTERF |
| Description | FUNCTION: Transcription termination factor. Binds to a 28 bp region within the tRNA(Leu(uur)) gene at a position immediately adjacent to and downstream of the 16S rRNA gene; this region comprises a tridecamer sequence critical for directing accurate termination. Binds DNA along the major grove and promotes DNA bending and partial unwinding. Promotes base flipping. Transcription termination activity appears to be polarized with highest specificity for transcripts initiated on the light strand. . FUNCTION: Transcription termination factor. Binds to a 28 bp region within the tRNA(Leu(uur)) gene at a position immediately adjacent to and downstream of the 16S rRNA gene; this region comprises a tridecamer sequence critical for directing accurate termination. Binds DNA along the major grove and promotes DNA bending and partial unwinding. Promotes base flipping. Transcription termination activity appears to be polarized with highest specificity for transcripts initiated on the light strand. . FUNCTION: Transcription termination factor. Binds to a 28 bp region within the tRNA(Leu(uur)) gene at a position immediately adjacent to and downstream of the 16S rRNA gene; this region comprises a tridecamer sequence critical for directing accurate termination. Binds DNA along the major grove and promotes DNA bending and partial unwinding. Promotes base flipping. Transcription termination activity appears to be polarized with highest specificity for transcripts initiated on the light strand. . FUNCTION: Transcription termination factor. Binds to a 28 bp region within the tRNA(Leu(uur)) gene at a position immediately adjacent to and downstream of the 16S rRNA gene; this region comprises a tridecamer sequence critical for directing accurate termination. Binds DNA along the major grove and promotes DNA bending and partial unwinding. Promotes base flipping. Transcription termination activity appears to be polarized with highest specificity for transcripts initiated on the light strand. . |
| Accessions | ENST00000351870.8 C9JNM8 ENST00000456229.1 ENST00000419292.1 C9JE25 B4DPR9 C9JU79 ENST00000442961.1 Q99551 ENST00000406735.6 ENST00000425936.1 |
